Use of combined inhalers for stable chronic obstructive pulmonary disease
Evidence & Practice    

Use of combined inhalers for stable chronic obstructive pulmonary disease

Amanda Wilson Senior lecturer, School of Nursing and Midwifery, University of Newcastle, New South Wales, Australia, and member of the Cochrane Nursing Care Field

The mission of the Cochrane Nursing Care Field (CNCF) is to improve health outcomes through increasing the use of the Cochrane Library and supporting Cochrane’s role by providing an evidence base for nurses and healthcare professionals who deliver, lead or research nursing care. The CNCF produces Cochrane Corner columns, summaries of recent nursing-care-relevant Cochrane Reviews that are regularly published in collaborating nursing-related journals. Information on the processes CNCF has developed can be accessed at: cncf.cochrane.org/evidence-transfer-program-review-summaries. This is a Cochrane review summary of: Horita N, Goto A, Shibata Y et al (2017) Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews. Issue 2. CD012066. doi: 10.1002/14651858.CD012066.pub2.

Nursing Standard. doi: 10.7748/ns.2018.e11125

@MediaDoctorAU

Correspondence

Amanda.wilson@newcastle.edu.au

Conflict of interest

None declared

Received: 29 January 2018

Accepted: 29 January 2018

Published online: 13 February 2018